Effect of radioprotective drugs on the therapeutic ratio for a mouse tumor system.
D000818:Animals; D003543:Cysteamine / Q000627:therapeutic use*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D008175:Lung Neoplasms; D008722:Methods; D051379:Mice; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009368:Neoplasm Transplantation; D010756:Phosphoric Acids / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental; D011837:Radiation-Protective Agents; D011855:Radiodermatitis; D011879:Radiotherapy Dosage; D012513:Sarcoma, Experimental / Q000401:mortality / Q000532:radiotherapy*; D012878:Skin Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D013455:Sulfur; D013997:Time Factors; D014184:Transplantation, Homologous
D010756:Phosphoric Acids; D011837:Radiation-Protective Agents; D003543:Cysteamine; D013455:Sulfur